1989 Miltenyi Biotec was founded in Bergisch Gladbach, Germany

>17,000 Products available worldwide

>3,500 Employees worldwide

23% Employees in global R&D

>20,000 Scientific publications

50 Nationalities within our staff

28 Countries with direct sales

73 Countries served through distributors

2,500 p.a. Patients treated annually with cell products using our technologies

>55,000 Cell therapy procedures with Miltenyi Biotec products

We look back at three decades of biomedical expertise and pioneer spirit. Throughout this time, we have continuously worked on the advancement of our technologies and collaborated with researchers around the world to push the boundaries of what is technically possible. 

• 1989 – Foundation of Miltenyi Biotec
• 2002 – Teterow GMP manufacturing facility
• 2008 – Medic Tools Sample preparation technology
• 2014 – MEMS chip technology
• 2014 – Lentiviral vector technology
• 2017 – Adapter CAR T technology
• 2017 – Smart imaging solution technology
• 2018 – CliniMACS Cell Factory® Bergisch Gladbach, GErmany,
• 2018 – Advanced optical technology
• 2019 – Image processing technology
• 2019 – Foundation Miltenyi Biomedicine
• 2019 – Next Generation Sequencing
• 2021 – CliniMACS Cell Factory® San José, CA, USA

At the heart of our business lies MACS Technology, a magnetic cell separation method based on the use of MACS Columns and MACS MicroBeads. Due to the gentle and effective nature of this method, isolated cell populations of interest are highly viable and pure. They can be used for a wide array of downstream applications including different research as well as clinical applications. Find out more about MACS Technology